(IMAGE)

Kumamoto University

Caption

The technology developed in this study enables the establishment of disease-specific hTSCs from placentas of patients with pregnancy complications. These cell lines are expected to provide a valuable platform for investigating the mechanisms underlying pregnancy disorders and for developing novel therapeutic strategies.

Credit

Hiroaki Okae (Kumamoto University)

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted.

License

CC BY-NC

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.